ReferIndia News FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms

ReferIndia News

Need a website for your NGO?

Build trust and reach more donors—FreeNGO creates powerful websites tailored for your cause.

Contact Now
News Image

FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms

Published on: Sept. 24, 2025, 1:21 a.m. | Source: Devdiscourse

The FDA has approved leucovorin, also known as folinic acid, for managing symptoms related to autism. The approval comes amid data on its efficacy for cerebral folate deficiency, associated with autism. Previously marketed as Wellcovorin, it was withdrawn not due to safety issues but business reasons.

Checkout more news
Ad Banner

One Partner for All Your Financial Goals

From financial planning and insurance to portfolio management and retirement solutions—get everything under one trusted roof.

Book Consultation
ReferIndia News contact